NKE
30
-3
URBN
72
-2
ETN
68
-4
EA
50
-4
KLAC
65
-6
GOOG
73
-2
PGR
53
-4
ZTS
31
-7
VNO
65
5
HRB
60
5
SYY
60
2
NWL
43
2
TRIP
40
2
CVS
56
2
IVZ
40
2
REGN
40
4
CINF
47
-6
TMO
47
4
CSCO
72
-11
ADP
68
-9
NKE
30
-3
URBN
72
-2
ETN
68
-4
EA
50
-4
KLAC
65
-6
GOOG
73
-2
PGR
53
-4
ZTS
31
-7
VNO
65
5
HRB
60
5
SYY
60
2
NWL
43
2
TRIP
40
2
CVS
56
2
IVZ
40
2
REGN
40
4
CINF
47
-6
TMO
47
4
CSCO
72
-11
ADP
68
-9
Financhill
Back

Apellis Pharmaceuticals Vs. EyePoint Pharmaceuticals Industry Stock Comparison

Sell
47

APLS
Apellis Pharmaceuticals

Last Price:
$19.57
Seasonality Move:
2.19%
Buy
53

EYPT
EyePoint Pharmaceuticals

Last Price:
$9.23
Seasonality Move:
-3.18%
Sell
47
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $19.58. The Score for APLS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
EyePoint Pharmaceuticals (EYPT) is a Buy

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $9.21. The Score for EYPT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • EYPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $19.58
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing slight selling pressure.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $9.21
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EYPT is experiencing slight selling pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.14 Buy
Relative Strength Index (14 RSI): 58.11 Buy
Chaikin Money Flow: -260707 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17 - 18.86) Buy
Bollinger Bands (100): (18.23 - 27.59) Sell

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 78.91 Buy
Chaikin Money Flow: -56338 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.6 - 7.94) Buy
Bollinger Bands (100): (5.53 - 7.57) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.84 Buy
20-day SMA: 17.92 Buy
50-day SMA: 18.66 Buy
200-day SMA: 27.56 Sell
8-day EMA: 18.9 Buy
20-day EMA: 18.44 Buy
50-day EMA: 19.52 Buy
200-day EMA: 27.59 Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.29 Buy
20-day SMA: 6.96 Buy
50-day SMA: 6.29 Buy
200-day SMA: 7.78 Buy
8-day EMA: 8.33 Buy
20-day EMA: 7.43 Buy
50-day EMA: 6.79 Buy
200-day EMA: 7.98 Buy

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.09 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):